… prostate cancer LNCaP and PC3 cells in vitro and in a mouse PC3 xenograft tumor model. …
also be at least partly responsible for the anti-tumor activity of ginsenosides. Nevertheless, the …

… (SE) and crocin (CR) exhibit anticancer activity by promoting cell cycle arrest in prostate …
-derived compounds maintain a differentiated state of prostate cancer cells, we analyzed the …

… behavior; however, a study of the antitumor efficacy of CT-NLC was lacking. … antitumor effects
of CT-NLC on prostate tumor cells in vitro and in vivo, and clarified the underlying antitumor …

… effect. Although PTU is known to induce hypothyroidism, we cannot necessarily conclude that
the antitumor effect is … of T 3 to determine whether the antitumor effect can be reversed. Our …

… development and progression, and inhibition of angiogenesis in preclinical models has …
prostate cancer. Thus, in this study, we used prostate cancer cells as a preclinical model to …

… arrest human prostate cancer cell … antitumor activity in xenograft models of prostate cancer
in nude mice, indicating that Lx2-32c might be a potential drug candidate for prostate cancer …

… the activity of topotecan on angiogenesis and directly on tumor … in drug activity against different
prostate cancer stages, we … its antitumor activity in a model of human prostate cancer after …

… kinase (HSV-tk) gene followed by ganciclovir is suspected to induce immune-mediated,
systemic antitumor activities in the RM-1 mouse prostate cancer model (SJ Hall et al., Int. J. …

… models of breast and ovarian cancer. The goal of this study was to determine in vivo anticancer
efficacy of α-TEA against human prostate cancer … anticancer activities in human prostate, …

… and potentiate the effect of DTX in prostate cancer models. We observed that co-administration
of DTX with NL sensitizes prostate cancer cells to DTX treatment, and this effect might be …